Rachel Epstein and Todd Anten are at the helm of Quinn Emanuel Urquhart & Sullivan, LLP‘s trade secrets team from its New York office. The team is well-equipped to represent its clients in matters regarding the alleged misappropriation of trade secrets. Across the team is a noteworthy specialism in litigation, which is used to represent clients with the array of IP issues. The industry sectors covered include gaming, media, tech and therapeutics and its workload frequently involves matters of multi-millions of dollars in value. Attorney Carey Ramos is a team member to note; he splits his time between Hong Kong and New York and has particularly notable capabilities in media and entertainment-related work and has experience representing clients in trade secret disputes regarding music and motion pictures. James Judah and associate Jocelyn Ma in San Francisco both harness expertise in tech-related cases. Team changes include the departure of litigator Steven Swedlow in November 2023, formerly based in Chicago; the resignation of Nina Tallon in November 2023 from the Washington DC office; and the departure of New York’s Thomas Pease to Greenberg Traurig LLP in July 2023.
Key clients
- Proofpoint, Inc.
- Primer Technologies
- Wisk Aero
- Snail Games USA Inc. and Wildcard Properties LLC
- Regor Therapeutics Inc.
- International Business Machines Corporation
- IBM World Trade Corporation
- IBM China Company Limited
- Rivos Inc. and Wen Shih-Chieh
- Life Spine, Inc.
Work highlights
- Secured a jury trial victory for Proofpoint, Inc., where the jury rendered a verdict that its competitor, Vade, wilfully and maliciously misappropriated Proofpoint’s trade secrets.
- Represented Wisk Aero and reached a favorable settlement in a trade secret misappropriation and patent infringement case against competitor Archer Aviation, involving allegations of illicit use of engineering files obtained from former employees.
- Representing pharmaceutical company Regor Therapeutics and two of its founders in a lawsuit brought by Pfizer, alleging that the companies made unauthorized use of Pfizer trade secrets and confidential information relating to the development of a treatment for diabetes.
Practice head
The lawyer(s) leading their teams.
Rachel Epstein, Todd Anten